273 related articles for article (PubMed ID: 37041543)
1. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
Grossman A; Prata N; Williams N; Ganatra B; Lavelanet A; Läser L; Asmani C; Elamin H; Ouedraogo L; Rahman MM; Conneh-Duworko MJ; Tehoungue BZ; Chanza H; Phiri H; Bhattarai B; Dhakal NP; Ojo OA; Afolabi K; Kabuteni TJ; Hailu BG; Moses F; Dlamini-Nqeketo S; Zulu T; Rehnström Loi U
Reprod Health; 2023 Apr; 20(Suppl 1):58. PubMed ID: 37041543
[TBL] [Abstract][Full Text] [Related]
2. In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
Rehnström Loi U; Prata N; Grossman A; Lavelanet A; Williams N; Ganatra B
Reprod Health; 2023 Jan; 20(Suppl 1):20. PubMed ID: 36694182
[TBL] [Abstract][Full Text] [Related]
3. Landscape assessment of the availability of medical abortion medicines in India.
Karna P; Sharma KA; Grossman A; Gupta M; Chatterjee T; Williams N; Prata N; Sorhaindo A; Läser L; Rehnström Loi U; Ganatra B; Chaudhary P
Reprod Health; 2024 Jun; 20(Suppl 1):193. PubMed ID: 38840263
[TBL] [Abstract][Full Text] [Related]
4. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
5. Strengthening regional commitment to ensuring access to medical abortion medicines in WHO's South-East Asia region: report of a participatory assessment and workshop.
Upadhyay MT; Fusire T; Loi UR; Sorhaindo A; Salahuddin M; Hossain MA; Tshomo T; Mulati E; Daisy L; Anggraweni DP; Gultom T; Indrawati F; Jenyfa M; Than MM; Bhattarai B; Moonasinghe L; Mathota C; Jitruknatee A; Cham C; Ganatra B; Raina N
Reprod Health; 2024 May; 20(Suppl 1):191. PubMed ID: 38760864
[TBL] [Abstract][Full Text] [Related]
6. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
Durocher J; Kilfedder C; Frye LJ; Winikoff B; Srinivasan K
Sex Reprod Health Matters; 2021 Dec; 29(1):1982460. PubMed ID: 34719353
[TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
[TBL] [Abstract][Full Text] [Related]
8. Self-administered versus provider-administered medical abortion.
Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
[TBL] [Abstract][Full Text] [Related]
9. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
Tamang A; Puri M; Lama K; Shrestha P
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
[TBL] [Abstract][Full Text] [Related]
10. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
11. Early abortion. Update and implications for midwifery practice.
Narrigan D
J Nurse Midwifery; 1998; 43(6):492-501. PubMed ID: 9871382
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
Frye LJ; Kilfedder C; Blum J; Winikoff B
Contraception; 2020 May; 101(5):315-320. PubMed ID: 32032639
[TBL] [Abstract][Full Text] [Related]
13. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
[TBL] [Abstract][Full Text] [Related]
14. Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
Chinery L; Allaouidine C; Tomazzini A; Larson M; Gülmezoglu AM
Reprod Health; 2020 Nov; 17(1):171. PubMed ID: 33148282
[TBL] [Abstract][Full Text] [Related]
15. The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
Lince-Deroche N; Constant D; Harries J; Kluge J; Blanchard K; Sinanovic E; Grossman D
PLoS One; 2018; 13(6):e0197485. PubMed ID: 29953434
[TBL] [Abstract][Full Text] [Related]
16. Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.
Kapp N; Methazia J; Eckersberger E; Griffin R; Bessenaar T
Contraception; 2020 Jan; 101(1):46-52. PubMed ID: 31655069
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
[TBL] [Abstract][Full Text] [Related]
18. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
[TBL] [Abstract][Full Text] [Related]
19. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
[TBL] [Abstract][Full Text] [Related]
20. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
Tamang A; Tamang J
Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
